Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. MET
MET logo

MET Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
70.885
Open
70.730
VWAP
70.03
Vol
4.17M
Mkt Cap
45.62B
Low
69.255
Amount
291.98M
EV/EBITDA(TTM)
10.98
Total Shares
652.05M
EV
61.76B
EV/OCF(TTM)
3.61
P/S(TTM)
0.61
MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.
Show More

Events Timeline

(ET)
2026-02-04
16:30:00
MetLife Reports Q4 Revenue of $23.81B, Below Consensus
select
2026-02-04
16:30:00
MetLife Reports Record Q4 Results, 10% Adjusted EPS Growth
select

News

moomoo
8.5
03-10moomoo
PinnedMetLife Inc. Gets Unsolicited Mini-Tender Proposal from Potemkin Limited to Acquire Up to 10,000 Shares
  • Company Announcement: Metlife Inc. has received an unsolicited mini-tender offer from Potemkin Limited.

  • Offer Details: The offer is for the purchase of up to 10,000 shares of Metlife Inc. stock.

moomoo
4.5
03-07moomoo
VERTIV HOLDINGS, LUMENTUM HOLDINGS, COHERENT, AND ECHOSTAR SET TO ENTER S&P 500
  • New Additions to S&P 500: Vertiv Holdings, Lumentum Holdings, Coherent, and Echosstar are set to join the S&P 500 index.

  • Market Impact: The inclusion of these companies may influence market dynamics and investor strategies as they become part of a major stock index.

moomoo
4.5
03-06moomoo
VERTIV HOLDINGS, LUMENTUM HOLDINGS, COHERENT, AND ECHOSTAR TO BE ADDED TO S&P 500; ADDITIONAL COMPANIES TO ENTER S&P 100, S&P MIDCAP 400, AND S&P SMALLCAP 600
  • New Additions to S&P 500: Vert Holdings, Lumentum Holdings, CohereNT, and EchoStar are set to join the S&P 500 index.

  • Other Index Changes: Additional companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.

Barron's
4.5
03-06Barron's
Vertiv, Lumentum, Coherent, and EchoStar Set to Enter S&P 500
  • Index Changes: S&P Dow Jones Indices is making significant adjustments to its major stock indexes this month.

  • New Additions: The changes include the addition of several technology and infrastructure companies.

  • Removals: Some well-known companies are being removed from the indexes as part of this reshuffling.

  • Market Impact: These adjustments may influence market dynamics and investor strategies moving forward.

Newsfilter
8.5
02-26Newsfilter
MetLife Issues $1 Billion Debentures Rated 'bbb+'
  • Debt Issuance Size: MetLife has successfully issued $1 billion in subordinated debentures at a 5.85% interest rate, which is expected to be utilized for general business purposes, thereby enhancing the company's capital structure and supporting future business expansion.
  • Stable Credit Rating: AM Best assigned a long-term credit rating of 'bbb+' to this debt issuance, indicating MetLife's robustness in the current market environment, while all other ratings remain unchanged, reflecting the company's overall financial health.
  • Financial Leverage Situation: MetLife's proforma adjusted financial leverage and historical interest coverage align with its current ratings, demonstrating effective debt management that helps bolster investor confidence in the company's financial stability.
  • Strong Liquidity: The holding company of MetLife exhibits strong liquidity, which secures its future financing activities and further solidifies its market position within the insurance industry.
Barron's
8.0
02-19Barron's
9 Robust Dividend Stocks as the Market Shifts Towards 'Tangible Assets'
  • Investment Opportunities: The current market conditions favor dividend stocks, providing opportunities for income-seeking investors.
  • Strategies for Investors: There are various strategies available for investors to capitalize on the potential growth of dividend stocks.
Wall Street analysts forecast MET stock price to rise
12 Analyst Rating
Wall Street analysts forecast MET stock price to rise
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
84.00
Averages
95.25
High
108.00
Current: 0.000
sliders
Low
84.00
Averages
95.25
High
108.00
Morgan Stanley
Bob Huang
Overweight
downgrade
$101 -> $93
AI Analysis
2026-03-03
Reason
Morgan Stanley
Bob Huang
Price Target
$101 -> $93
AI Analysis
2026-03-03
downgrade
Overweight
Reason
Morgan Stanley analyst Bob Huang lowered the firm's price target on MetLife to $93 from $101 and keeps an Overweight rating on the shares. The firm is updating its price targets for Insurance - Life/Annuity North America stocks under its coverage, the analyst tells investors. While Morgan Stanley is not concerned about life insurers' exposure to private credit, the broader industry will likely feel pressure on their valuation.
Wells Fargo
Elyse Greenspan
Overweight -> Overweight
downgrade
$97 -> $93
2026-02-25
Reason
Wells Fargo
Elyse Greenspan
Price Target
$97 -> $93
2026-02-25
downgrade
Overweight -> Overweight
Reason
Wells Fargo analyst Elyse Greenspan lowered the firm's price target on MetLife to $93 from $97 and keeps an Overweight rating on the shares. With guidance from most companies in Q4, the firm is generally reducing its EPS estimates as guides were in-line to below consensus expectations for most companies. Wells is also rolling valuation methodologies to 2027 EPS and rolling out new 2028E EPS estimates for companies.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MET
Unlock Now

Valuation Metrics

The current forward P/E ratio for MetLife Inc (MET.N) is 8.29, compared to its 5-year average forward P/E of 8.53. For a more detailed relative valuation and DCF analysis to assess MetLife Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
8.53
Current PE
8.29
Overvalued PE
9.46
Undervalued PE
7.60

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
3.94
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
9.93
Undervalued EV/EBITDA
-2.05

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.72
Current PS
0.59
Overvalued PS
0.80
Undervalued PS
0.65

Financials

AI Analysis
Annual
Quarterly

Whales Holding MET

E
Epoch Investment Partners, Inc.
Holding
MET
+9.05%
3M Return
G
Graham Capital Management, L.P.
Holding
MET
+5.07%
3M Return
G
Groupama Asset Management SA
Holding
MET
+4.66%
3M Return
G
General American Investors Company, Inc.
Holding
MET
+3.64%
3M Return
O
Occudo Quantitative Strategies LP
Holding
MET
+1.97%
3M Return
A
Applied Finance Advisors, LLC
Holding
MET
+1.75%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is MetLife Inc (MET) stock price today?

The current price of MET is 69.96 USD — it has decreased -0.91

What is MetLife Inc (MET)'s business?

MetLife, Inc. is a financial services company, providing insurance, annuities, employee benefits and asset management to individual and institutional customers. Its segments include Group Benefits; Retirement and Income Solutions (RIS); Asia; Latin America; Europe, the Middle East and Africa (EMEA); and MetLife Holdings. Group Benefits segment offers life insurance, dental, group short- and long-term disability, paid family and medical leave, individual disability, accidental death and dismemberment insurance, accident and health insurance, and vision, as well as prepaid legal plans and pet insurance. RIS segment provides funding and financing solutions that help institutional customers mitigate and manage liabilities primarily associated with their employee benefit programs using a spectrum of life and annuity-based insurance and investment products. It operates across EMEA in both developed (Western Europe) and emerging (Central and Eastern Europe, Middle East and Africa) markets.

What is the price predicton of MET Stock?

Wall Street analysts forecast MET stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MET is95.25 USD with a low forecast of 84.00 USD and a high forecast of 108.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is MetLife Inc (MET)'s revenue for the last quarter?

MetLife Inc revenue for the last quarter amounts to 23.67B USD, increased 26.69

What is MetLife Inc (MET)'s earnings per share (EPS) for the last quarter?

MetLife Inc. EPS for the last quarter amounts to 1.17 USD, decreased -34.27

How many employees does MetLife Inc (MET). have?

MetLife Inc (MET) has 46000 emplpoyees as of March 12 2026.

What is MetLife Inc (MET) market cap?

Today MET has the market capitalization of 45.62B USD.